Heart failure and cognitive dysfunction

International Journal of Cardiology

Volumn 178, Issue , 2015, Pages 12-23

  Ampadu, James ^a   Morley, John E ^b  

^a SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive impairment; Delirium; Dementia; Dementia screening; Heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOOXYGENASE 2; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; HOMOCYSTEINE; INTERLEUKIN 1; INTERLEUKIN 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADL DISABILITY; ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN HYPOXIA; BRAIN PERFUSION; CACHEXIA; CARDIAC RESYNCHRONIZATION THERAPY; COGNITIVE DEFECT; CONGESTIVE HEART FAILURE; COUNTERPULSATION; CYTOKINE PRODUCTION; DELIRIUM; DEMENTIA; DEPRESSION; EXERCISE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HOSPITAL READMISSION; HUMAN; HYPERGLYCEMIA; HYPERHOMOCYSTEINEMIA; HYPOGLYCEMIA; HYPONATREMIA; LACUNAR STROKE; MICROEMBOLISM; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MORTALITY; NEUROIMAGING; NEW YORK HEART ASSOCIATION CLASS; NONHUMAN; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PREVALENCE; PROTEIN CALORIE MALNUTRITION; REVIEW; SCREENING TEST; SYSTEMATIC REVIEW; WHITE MATTER; COGNITION DISORDERS; HUMANS; PSYCHOLOGY;

COGNITION DISORDERS; HEART FAILURE; HUMANS;

EID: 84916202491     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.10.087     Document Type: Review

References (184)

1. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, W.B. Borden, D.M. Bravata, S. Dai, E.S. Ford, C.S. Fox, S. Franco, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, M.D. Huffman, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D. Magid, G.M. Marcus, A. Marelli, D.B. Matchar, D.K. McGuire, E.R. Mohler, C.S. Moy, M.E. Mussolino, G. Nichol, N.P. Paynter, P.J. Schreiner, P.D. Sorlie, J. Stein, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, M.B. Turner, and American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 143 152
2. G. Zuccalà, E. Marzetti, M. Cesari, M.R. Lo Monaco, L. Antonica, A. Cocchi, P. Carbonin, and R. Bernabei Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey Am. J. Med. 118 2005 496 502
3. G. Zuccalà, C. Cattel, E. Manes-Gravina, M.G. Di Niro, A. Cocchi, and R. Bernabei Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure J. Neurol. Neurosurg. Psychiatry 63 1997 509 512
4. R. Schmidt, F. Fazekas, H. Offenbacher, J. Dusleag, and H. Lechner Brain magnetic resonance imaging and neuropsychologic evaluation of patients with idiopathic dilated cardiomyopathy Stroke 22 1991 195 199
5. M.L. Alosco, A.M. Brickman, M.B. Spitznagel, S.L. Garcia, A. Narkhede, E.Y. Griffith, N. Raz, R. Cohen, L.H. Sweet, L.H. Colbert, R. Josephson, J. Hughes, J. Rosneck, and J. Gunstad Cerebral perfusion is associated with white matter hyperintensities in older adults with heart failure Congest. Heart Fail. 19 2013 E29 E34
6. O.P. Almeida, G.J. Garrido, C. Beer, N.T. Lautenschlager, L. Arnolda, and L. Flicker Cognitive and brain changes associated with ischaemic heart disease and heart failure Eur. Heart J. 33 2012 1769 1776
7. J. Cameron, L. Worrall-Carter, K. Page, S. Stewart, and C.F. Ski Screening for mild cognitive impairment in patients with heart failure: Montreal cognitive assessment versus mini mental state exam Eur. J. Cardiovasc. Nurs. 12 2013 252 260
8. S.I. Chaudhry, G. McAvay, S. Chen, H. Whitson, A.B. Newman, H.M. Krumholz, and T.M. Gill Risk factors for hospital admission among older persons with newly diagnosed heart failure: findings from the Cardiovascular Health Study J. Am. Coll. Cardiol. 61 2013 635 642
9. M.L. Alosco, M.B. Spitznagel, M. van Dulmen, N. Raz, R. Cohen, L.H. Sweet, L.H. Colbert, R. Josephson, J. Hughes, J. Rosneck, and J. Gunstad Cognitive function and treatment adherence in older adults with heart failure Psychosom. Med. 74 2012 965 973
10. T.R. Gure, C.S. Blaum, and K.M. Langa The prevalence of cognitive impairment in older adults with heart failure J. Am. Geriatr. Soc. 60 2012 1724 1729
11. S. Debette, C. Bauters, D. Leys, N. Lamblin, F. Pasquier, and P. de Groote Prevalence and determinants of cognitive impairment in chronic heart failure patients Congest. Heart Fail. 13 2007 205 208
12. J.A. Dodson, and S.I. Chaudhry Geriatric conditions in heart failure Curr. Cardiovasc. Risk Rep. 6 2012 404 410
13. K. Harkness, C. Demers, G.A. Heckman, and R.S. McKelvie Screening for cognitive deficits using the Montreal Cognitive Assessment Tool in outpatients ≥ 65 years of age with heart failure Am. J. Cardiol. 107 2011 1203 1207
14. L. Trojano, R. Antonelli Incalzi, D. Acanfora, C. Picone, P. Mecocci, and F. Rengo Cognitive impairment: a key feature of congestive heart failure in the elderly J. Neurol. 250 2003 1456 1463
15. M.L. Alosco, M.B. Spitznagel, N. Raz, R. Cohen, L.H. Sweet, L.H. Colbert, R. Josephson, M. van Dulmen, J. Hughes, J. Rosneck, and J. Gunstad Obesity interacts with cerebral hypoperfusion to exacerbate cognitive impairment in older adults with heart failure Cerebrovasc. Dis. Extra 2 2012 88 98
16. J.A. Dodson, and S.I. Chaudhry Geriatric conditions in heart failure Curr. Cardiovasc. Risk Rep. 6 2012 404 410
17. E.M. Reiman, J.B.S. Langbaum, and P.N. Tariot Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible Biomark. Med 4 1 Feb 2010 3 14
18. T.F. Hughes, B.E. Snitz, and M. Ganguli Should mild cognitive impairment be subtyped? Curr. Opin. Psychiatry 24 3 2011 237 242
19. M. Huijts, R.J. van Oostenbrugge, A. Duits, T. Burkard, S. Muzzarelli, M.T. Maeder, R. Schindler, M.E. Pfisterer, and H.P. Brunner-La Rocca TIME-CHF investigators. Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial Eur. J. Heart Fail. 15 6 Jun 2013 699 707
20. M. Belohlavek, P. Jiamsripong, A.M. Calleja, E.M. McMahon, C.L. Maarouf, T.A. Kokjohn, T.L. Chaffin, L.J. Vedders, Z. Garami, T.G. Beach, M.N. Sabbagh, and A.E. Roher Patients with Alzheimer disease have altered transmitral flow: echocardiographic analysis of the vortex formation time J. Ultrasound Med. 28 11 Nov 2009 1493 1500
21. C. Hjelm, A. Broström, A. Dahl, B. Johansson, M. Fredrikson, and A. Strömberg Factors associated with increased risk for dementia in individuals age 80 years or older with congestive heart failure J. Cardiovasc. Nurs. 29 1 Jan-Feb 2014 82 90
22. Chengxuan Qiu, Eva von Strauss, Johan Fastbom, Bengt Winblad, and Laura Fratiglioni Low blood pressure and risk of dementia in the Kungsholmen project - a 6-year follow up study Arch. Neurol. 60 2 2003 223 228
23. C. Qiu, B. Winblad, A. Marengoni, I. Klarin, J. Fastbom, and L. Fratiglioni Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study Arch. Intern. Med. 166 9 May 8 2006 1003 1008
24. M.A. Hawkins, J. Gunstad, M. Dolansky, J.D. Redle, R. Josephson, S.M. Moore, and J.W. Hughes Greater body mass index is associated with poorer cognitive functioning in male heart failure patients J. Card. Fail. 20 2014 199 206
25. F. Formiga, D. Chivite, A. Conde, F. Ruiz-Laiglesia, A.G. Franco, C.P. Bocanegra, L. Manzano, M.M. Pérez-Barquero, and RICA Investigators Basal functional status predicts three-month mortality after a heart failure hospitalization in elderly patients - the prospective RICA study Int. J. Cardiol. 172 2014 127 131
26. S. Debette, and H.S. Markus The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis BMJ 341 2010 c3666
27. M.L. Alosco, A.M. Brickman, M.B. Spitznagel, S.L. Garcia, A. Narkhede, E.Y. Griffith, N. Raz, R. Cohen, L.H. Sweet, L.H. Colbert, R. Josephson, J. Hughes, J. Rosneck, and J. Gunstad Cerebral perfusion is associated with white matter hyperintensities in older adults with heart failure Congest. Heart Fail. 19 2013 E29 E34
28. E. Dardiotis, G. Giamouzis, D. Mastrogiannis, C. Vogiatzi, J. Skoularigis, F. Triposkiadis, and G.M. Hadjigeorgiou Cognitive impairment in heart failure Cardiol. Res. Pract. June 6 2012 10.1155/2012/595 821 (Epub)
29. C.A. Sila Cognitive impairment in chronic heart failure Clev. Clin. J. Med. 74 Suppl. 1 2007 S132 S137
30. J.C. De la Torre Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia Cardiovasc. Psychiatry Neurol. 2012 2012 367516
31. T.C. Alves, and G.F. Busatto Regional cerebral blood flow reductions, heart failure and Alzheimer's disease Neurol. Res. 28 6 Sep 2006 579 587
32. C. Beer, E. Ebenezer, S. Fenner, N.T. Lautenschlager, L. Arnolda, L. Flicker, and O.P. Almeida Contributors to cognitive impairment in congestive heart failure: a pilot case-control study Int. Med. J. 39 2009 600 605
33. R.L. Vogels, J.M. Oosterman, B. van Harten, A.A. Gouw, J.M. Schroeder-Tanka, P. Scheltens, W.M. van der Flier, and H.C. Weinstein Neuroimaging and correlates of cognitive function among patients with heart failure Dement. Geriatr. Cogn. Disord. 24 2007 418 423
34. O.P. Almeida, G.J. Garrido, C. Etherton-Beer, N.T. Lautenschlager, L. Arnolda, H. Alfonso, and L. Flicker Brain and mood changes over 2 years in healthy controls and adults with heart failure and ischaemic heart disease Congest. Heart Fail. 19 2013 E29 E34
35. T. Rutledge, V.A. Reis, S.E. Linke, B.H. Greenberg, and P.J. Mills Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes J. Am. Coll. Cardiol. 48 2006 1527 1537
36. J.K. Rustad, T.A. Stern, K.A. Hebert, and D.L. Musselman Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature Prim. Care Companion C.N.S. Disord. 15 2013 (Aug 15. pii: PCC.13r01511. Epub ahead of print)
37. J.E. Morley Depression in nursing home residents J. Am. Med. Dir. Assoc. 11 2010 301 303
38. M. Thakur, and D.G. Blazer Depression in long-term care J. Am. Med. Dir. Assoc. 9 2008 82 87
39. O. Hanon, J.S. Vidal, P. de Groote, M. Galinier, R. Isnard, D. Logeart, and M. Komajda Prevalence of memory disorders in ambulatory patients aged ≥ 70 years with chronic heart failure (from the EFICARE study) Am. J. Cardiol. 113 2014 1205 1210
40. M.L. Alosco, M.B. Spitznagel, N. Raz, R. Cohen, L.H. Sweet, S. Garcia, R. Josephson, M. van Dulmen, J. Hughes, J. Rosneck, and J. Gunstad The interactive effects of cerebral perfusion and depression on cognitive function in older adults with heart failure Psychosom. Med. 75 2013 632 639
41. T. West, M.C. Pruchnicki, K. Porter, and R. Emptage Evaluation of anticholinergic burden of medications in older adults J. Am. Pharm. Assoc. 53 2003 496 504
42. S.P. Fitzgerald, and N.G. Bean An analysis of the interactions between individual comorbidities and their treatments - implications for guidelines and polypharmacy J. Am. Med. Dir. Assoc. 11 2010 475 484
43. J.E. Morley Anticholinergic medications and cognition J. Am. Med. Dir. Assoc. 12 2011 543-543 (e1)
44. E. Lowry, R.J. Woodman, R.L. Soiza, and A.A. Mangoni Associations between the anticholinergic risk scale score and physical function: potential implications for adverse outcomes in older hospitalized patients J. Am. Med. Dir. Assoc. 12 2011 565 572
45. M.O. Little, and A. Morley Reducing polypharmacy: evidence from a simple quality improvement initiative J. Am. Med. Dir. Assoc. 14 2013 152 156
46. M.T. Beier Updated 2012 Beers criteria: what's noteworthy and cautionary? J. Am. Med. Dir. Assoc. 13 2012 768 769
47. G. Colloca, M. Tosato, D.L. Vetrano, E. Topinkova, D. Fialova, J. Gindin, H.G. van der Roest, F. Landi, R. Liperoti, R. Bernabei, G. Onder, and SHELTER project Inappropriate drugs in elderly patients with severe cognitive impairment: results from the shelter study PLoS One 7 10 2012 e46669
48. K.M. Sink, X. Leng, J. Williamson, S.B. Kritchevsky, K. Yaffe, L. Kuller, S. Yasar, H. Atkinson, M. Robbins, B. Psaty, and D.C. Goff Jr. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study Arch. Intern. Med. 169 2009 1195 1202
49. G.B. Rattinger, S.K. Dutcher, P.T. Chhabra, C.S. Franey, L. Simoni-Wastila, S.S. Gottlieb, B. Stuart, and I.H. Zuckerman The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure Am. J. Geriatr. Pharmacother. 10 2012 69 80
50. A. Laudisio, E. Marzetti, F. Pagano, A. Cocchi, R. Bernabei, and G. Zuccalá Digoxin and cognitive performance in patients with heart failure: a cohort, pharmacoepidemiological survey Drugs Aging 26 2009 103 112
51. J. Farkas, S. von Haehling, I.K. Kalantar-Zadeh, J.E. Morley, S.D. Anker, and M. Lainscak Cachexia as a major public health problem: frequent, costly, and deadly J. Cachex. Sarcopenia Muscle 4 2013 173 178
52. J.M. Argilés, S.D. Anker, W.J. Evans, J.E. Morley, K.C. Fearon, F. Strasser, M. Muscaritoli, and V.E. Baracos Consensus on cachexia definitions J. Am. Med. Dir. Assoc. 11 2010 229 230
53. W.J. Evans, J.E. Morley, J. Argilés, C. Bales, V. Baracos, D. Guttridge, A. Jatoi, K. Kalantar-Zadeh, H. Lochs, G. Mantovani, D. Marks, W.E. Mitch, M. Muscaritoli, A. Najand, P. Ponikowski, F. Rossi Fanelli, M. Schambelan, A. Schols, M. Schuster, D. Thomas, R. Wolfe, and S.D. Anker Cachexia: a new definition Clin. Nutr. 27 2008 793 799
54. G. Zuccala, E. Marzetti, M. Cesari, M.R. Lo Monaco, L. Antonica, A. Cocchi, P. Carbonin, and R. Bernabei Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey Am. J. Med. 118 2005 496 502
55. J.E. Morley Weight loss in older persons: new therapeutic approaches Curr. Pharm. Des. 13 2007 3637 3647
56. J.E. Morley Undernutrition: a major problem in nursing homes J. Am. Med. Dir. Assoc. 12 2011 243 246
57. D. Del Sindaco, G. Pulignano, A. Di Lenarda, L. Tarantini, G. Cioffi, S. Tolone, M.D. Tinti, L. Monzo, G. Barbati, and G. Minardi Role of a multidisciplinary program in improving outcomes in cognitively impaired heart failure older patients Monaldi Arch. Chest Dis. 78 2012 20 28
58. J.M. Pappachan, G.I. Varughese, R. Sriraman, and G. Arunagirinathan Diabetic cardiomyopathy: pathophysiology, diagnostic evaluation and management World J. Diabetes 4 2013 177 189
59. J.P. Ryan, D.F. Fine, and C. Rosano Type 2 diabetes and cognitive impairment: contributions from neuroimaging J. Geriatr. Psychiatry Neurol. 27 2014 47 55
60. A. Sinclair, and J.E. Morley How to manage diabetes mellitus in older persons in the 21st century: applying these principles to long term diabetes care J. Am. Med. Dir. Assoc. 14 2013 777 780
61. L.H. Mallery, T. Ransom, B. Steeves, B. Cook, P. Dunbar, and P. Moorhouse Evidence-informed guidelines for treating frail older adults with type 2 diabetes: from the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) program J. Am. Med. Dir. Assoc. 14 2013 801 808
62. A. Sinclair, J.E. Morley, L. Rodriguez-Mañas, G. Paolisso, T. Bayer, A. Zeyfang, I. Bourdel-Marchasson, U. Vischer, J. Woo, I. Chapman, T. Dunning, G. Meneilly, J. Rodriguez-Saldana, L.M. Gutierrez Robledo, T. Cukierman-Yaffe, R. Gadsby, G. Schernthaner, and K. Lorig Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes J. Am. Med. Dir. Assoc. 13 2012 497 502
63. J.F. Flood, A.D. Mooradian, and J.E. Morley Characteristics of learning and memory in streptozocin-induced diabetic mice Diabetes 39 1990 1391 1398
64. J.E. Morley Cognition and nutrition Curr. Opin. Clin. Nutr. Metab. Care 17 2014 1 4
65. S.A. Farr, K.A. Yamada, D.A. Butterfield, H.M. Abdul, L. Xu, N.E. Miller, W.A. Banks, and J.E. Morley Obesity and hypertriglyceridemia produce cognitive impairment Endocrinology 149 2008 2628 2636
66. W.A. Banks, S.A. Farr, and J.E. Morley The effects of high fat diets on the blood-brain barrier transport of leptin: failure or adaptation? Physiol. Behav. 88 2006 244 248
67. S.A. Farr, W.A. Banks, and J.E. Morley Effects of leptin on memory processing Peptides 27 2006 1420 1425
68. E.A. Jankowska, B. Biel, J. Majda, A. Szklarska, M. Lopuszanska, M. Medras, S.D. Anker, W. Banasiak, P.A. Poole-Wilson, and P. Ponikowski Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival Circulation 114 2006 1829 1837
69. A. Florvaag, V. Oberle, M. Fritzenwanger, D. Kretschmar, S. Betge, B. Goebel, D. Barz, M. Ferrari, H.R. Figulla, M. Franz, and C. Jung Testosterone deficiency in male heart failure patients and its effect on endothelial progenitor cells Aging Male 15 2012 180 186
70. J.E. Morley, F. Kaiser, W.J. Raum, H.M. Perry III, J.F. Flood, J. Jensen, A.J. Silver, and E. Roberts Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone Proc. Natl. Acad. Sci. U. S. A. 94 1997 7537 7542
71. L.W. Chu, S. Tam, R.L. Wong, P.Y. Yik, Y. Song, B.M. Cheung, J.E. Morley, and K.S. Lam Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men J. Alzheimers Dis. 21 2010 1335 1345
72. L.W. Chu, S. Tam, P.W. Lee, R.L. Wong, P.Y. Yik, W. Tsui, Y. Song, B.M. Cheung, J.E. Morley, and K.S. Lam Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men Clin. Endocrinol. (Oxf) 68 2008 589 598
73. J.F. Flood, S.A. Farr, F.E. Kaiser, M. La Regina, and J.E. Morley Age-related decrease of plasma testosterone in SAMP8 mice: replacement improves age-related impairment of learning and memory Physiol. Behav. 57 1995 669 673
74. M.M. Cherrier, A.M. Matsumoto, J.K. Amory, S. Asthana, W. Bremner, E.R. Peskind, M.A. Raskind, and S. Craft Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment Neurology 64 2005 2063 2068
75. M.M. Cherrier Testosterone effects on cognition in health and disease Front. Horm. Res. 37 2009 150 162
76. M.M. Cherrier, A.M. Matsumoto, J.K. Amory, M. Johnson, S. Craft, E.R. Peskind, and M.A. Raskind Characterization of verbal and spatial memory changes in from moderate to supraphysiological increases in serum testosterone in healthy older men Psychoneuroendocrinology 32 2007 72 79
77. J.E. Morley Alzheimer's disease: future treatments J. Am. Med. Dir. Assoc. 12 2011 1 7
78. H. Villars, S. Oustric, S. Andrieu, J.P. Baeyens, R. Bernabei, H. Brodaty, K. Brummel-Smith, C. Celafu, N. Chappell, J. Fitten, G. Frisoni, L. Froelich, O. Guerin, G. Gold, I. Holmerova, S. Iliffe, A. Lukas, R. Melis, J.E. Morley, H. Nies, F. Nourhashemi, J. Petermans, J. Ribera Casado, L. Rubenstein, A. Salva, C. Sieber, A. Sinclair, R. Schindler, E. Stephan, R.Y. Wong, and B. Vellas The primary care physician and Alzheimer's disease: an international position paper J. Nutr. Health Aging 14 2010 110 120
79. S. Joshi, and J.E. Morley Cognitive impairment Med. Clin. North Am. 90 2006 769 787
80. S. Engelhardt, S. Patkar, and O.O. Ogunshola Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia Br. J. Pharmacol. 171 2014 1210 1230
81. O.O. Ogunshola, and A. Al-Ahmad HIF-1 at the blood-brain barrier: a mediator of permeability? High. Alt. Med. Biol. 13 2012 153 161
82. S. Engelhardt, A.J. Al-Ahmad, M. Gassmann, and O.O. Ogunshola Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes through a hypoxia-inducible factor-1 (HIF-1) dependent mechanism J. Cell. Physiol. 229 8 Dec 25 2013 1096 1105
83. N. Singh, G. Sharma, V. Mishra, and R. Raghubir Hypoxia inducible factor-1: its potential role in cerebral ischemia Cell. Mol. Neurobiol. 32 2012 491 507
84. W. Chen, V. Jadhav, J. Tang, and J.H. Zhang HIF-1 alpha inhibition ameliorates neonatal brain damage after hypoxic-ischemic injury Acta Neurochir. Suppl. 102 2008 395 399
85. Y.L. Wang, Y.N. Hui, B. Guo, and J.X. Ma Strengthening tight junctions of retinal microvascular endothelial cells by pericytes under normoxia and hypoxia involving angiopoietin-1 signal way Eye 21 2007 1501 1510
86. B. Reuss, R. Dono, and K. Unsicker Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood-brain barrier permeability: evidence from mouse mutants J. Neurosci. 23 2003 6404 6412
87. C. Iacovetta, E. Rudloff, and R. Kirby The role of aquaporin 4 in the brain Vet. Clin. Pathol. 41 2012 32 44
88. N. Saito, H. Ikegami, and K. Shimada Effect of water deprivation on aquaporin 4 (AQP4) mRNA expression in chickens (Gallus domesticus) Brain Res. Mol. Brain Res. 141 2005 193 197
89. F. Umenishi, A.S. Verkman, and M.A. Gropper Quantitative analysis of aquaporin mRNA expression in rat tissues by RNase protection assay DNA Cell Biol. 6 1996 475 480
90. B.J. Kolber, M. Key, C. Yanfang, M. Morris, and C. Krane Aquaporin 4 mRNA expression in mouse brain is induced in response to dehydration FASEB J. 17 2003 4 5
91. A. Sfera, and C. Osorio Water for thought: is there a role for aquaporin channels in delirium? Front. Psychiatry 2014 5 (May)
92. J.E. Morley, and S.A. Farr The role of amyloid-beta in the regulation of memory Biochem. Pharmacol. 88 2014 479 485
93. J.E. Morley, S.A. Farr, V.B. Kumar, and H.J. Armbrecht The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease Curr. Pharm. Des. 18 2012 1123 1130
94. X. Hong, L. Bu, Y. Wang, J. Xue, J. Wu, Y. Huang, J. Liu, H. Suo, L. Yang, Y. Shi, Y. Lou, Z. Sun, G. Zhu, T. Behnisch, M. Yu, J. Jia, W. Hai, H. Meng, S. Liang, F. Huang, Y. Zou, and J. Ge Increases in the risk of cognitive impairment and alterations of cerebral β-amyloid metabolism in mouse model of heart failure PLoS One 8 5 2013 e63829
95. S.D. Anker, and S. von Haehling Inflammatory mediators in chronic heart failure: an overview Heart 90 2004 464 470
96. P. Aukrust, L. Gullestad, T. Ueland, J.K. Damas, and A. Yndestad Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implication Ann. Med. 37 2005 74 85
97. P. Athilingam, J. Moynihan, L. Chen, R. D'Aoust, M. Groer, and K. Kip Elevated levels of interleukin 6 and C-reactive protein association with cognitive impairment in heart failure Congest. Heart Fail. 19 2013 92 98
98. C.J. Wilson, C.E. Finch, and H.J. Cohen Cytokines and cognition - the case for a head-to-toe inflammatory paradigm J. Am. Geriatr. Soc. 50 2002 2041 4056
99. M. Bianchi, P. Sacerdote, and A.E. Panerai Cytokines and cognitive function in mice Biol. Signals Recept. 7 1998 45 54
100. J. McAfoose, and B.T. Baune BT Evidence for a cytokine model of cognitive function Neurosci. Biobehav. Rev. 33 2009 355 366
101. P. Gonzalez, I. Machado, A. Vilcaes, C. Caruso, G.A. Roth, H. Schioth, M. Lsaga, and T. Scimonelli Molecular mechanisms involved in interleukin 1-beta (IL-1β)-induced memory impairment. Modulation by alpha-melanocyte-stimulating hormone (α-MSH) Brain Behav. Immun. 34 2013 141 150
102. D. Srinivasan, J.H. Yen, D.J. Joseph, and W. Friedman Cell type-specific interleukin-1beta signaling in the CNS J. Neurosci. 24 2004 6482 6488
103. L.P. Kapcala, J.R. He, Y. Gao, J.O. Pieper, and L.J. DeTolla Subdiaphragmatic vagotomy inhibits intra-abdominal interleukin-1 beta stimulation of adrenocorticotropin secretion Brain Res. 728 1996 247 254
104. B. Sousa-Pinto, M. Ferreira-Pinto, M. Santos, and A.F. Leite-Moreira Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications Heart Fail. Rev. 19 6 February 27, 2014 759 779
105. J.F. Flood, M.O. Merbaum, and J.E. Morley The memory enhancing effects of cholecystokinin octapeptide are dependent on an intact stria terminalis Neurobiol. Learn. Mem. 64 1995 139 145
106. J.F. Flood, J.S. Garland, and J.E. Morley Evidence that cholecystokinin-enhanced retention is mediated by changes in opioid activity in the amygdala Brain Res. 585 1992 94 104
107. W.A. Banks, S.A. Farr, and J.E. Morley Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes Neuroimmunomodulation 10 2002-2003 319 327
108. W.A. Banks, S.A. Farr, M.E. La Scola, and J.E. Morley Intravenous human interleukin-alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum J. Pharmacol. Exp. Ther. 299 2001 536 541
109. Z.H. Zhang, Y. Yu, S.G. Wei, Y. Nakamura, K. Nakamura, and R.B. Felder EP(3) receptors mediate PGE(2)-induced hypothalamic paraventricular nucleus excitation and sympathetic activation Am. J. Physiol. Heart Circ. Physiol. 301 2011 H1559 H1569
110. A. Ericsson, C. Arias, and P.E. Sawchenko Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1 J. Neurosci. 17 1997 7166 7179
111. R. Yirmiya, and I. Goshen Immune modulation of learning, memory, neural plasticity and neurogenesis Brain Behav. Immun. 25 2011 181 213
112. D. Tanokashira, T. Morita, K. Hayashi, T. Mayanagi, K. Fukumoto, Y. Kubota, T. Yamashita, and K. Sobue Glucocorticoid suppresses dendritic spine development mediated by down-regulation of caldesmon expression J. Neurosci. 32 2012 14583 14591
113. E. Okuyan, A. Uslu, M.A. Cakar, I. Sahin, I. Onür, A. Enhos, H.I. Biter, S. Cetin, and M.H. Dinçkal Homocysteine levels in patients with heart failure with preserved ejection fraction Cardiology 117 2010 21 27
114. R.S. Schofield, T.R. Wessel, T.C. Walker, T.S. Cleeton, J.A. Hill, and J.M. Aranda Jr. Hyperhomocysteinemia in patients with heart failure referred for cardiac transplantation: preliminary observations Clin. Cardiol. 26 2003 407 410
115. R.P. Kloppenborg, P.J. Nederkoorn, Y. van der Graaf, and M.I. Geerlings Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study Atherosclerosis 216 2011 461 466
116. R.P. Kloppenborg, P.J. Nederkoorn, A.M. Grool, K.L. Vincken, W.P. Mali, M. Vermeulen, Y. van der Graaf, M.I. Geerlings, and SMART Study Group Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study Neurology 79 2012 2029 2036
117. C. Dufouil, A. Alpérovitch, V. Ducros, and C. Tzourio Homocysteine, white matter hyperintensities, and cognition in healthy elderly people Ann. Neurol. 53 2003 214 221
118. B.C. Rhodehouse, M.A. Erickson, W.A. Banks, and S.E. Bearden Hyperhomocysteinemic mice show cognitive impairment without features of Alzheimer's disease phenotype J. Alzheimers Dis. 35 2013 59 66
119. L. Gao, X.N. Zeng, H.M. Guo, X.M. Wu, H.J. Chen, R.K. Di, and Y. Wu Cognitive and neurochemical alterations in hyperhomocysteinemic rat Neurol. Sci. 33 2012 39 43
120. S.O. Loureiro, L. Romão, T. Alves, A. Fonseca, L. Heimfarth, V. Moura Neto, A.T. Wyse, and R. Pessoa-Pureur Homocysteine induces cytoskeletal remodeling and production of reactive oxygen species in cultured cortical astrocytes Brain Res. 1355 2010 151 164
121. C. Matté, V. Mackedanz, F.M. Stefanello, E.B. Scherer, A.C. Andreazza, C. Zanotto, A.M. Moro, S.C. Garcia, C.A. Gonçalves, B. Erdtmann, M. Salvador, and A.T. Wyse Chronic hyperhomocysteinemia alters antioxidant defenses and increases DNA damage in brain and blood of rats: protective effect of folic acid Neurochem. Int. 54 2009 7 13
122. L.G. Rabaneda, M. Carrasco, M.A. López-Toledano, M. Murillo-Carretero, F.A. Ruiz, C. Estrada, and C. Castro Homocysteine inhibits proliferation of neuronal precursors in the mouse adult brain by impairing the basic fibroblast growth factor signaling cascade and reducing extracellular regulated kinase 1/2-dependent cyclin E expression FASEB J. 22 2008 3823 3835
123. J.M. Zhuo, and D. Praticò Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer's disease FASEB J. 24 2010 3895 3902
124. J. Gunstad, A. Poppas, S. Smeal, R.H. Paul, D.F. Tate, A.L. Jefferson, D.E. Forman, and R.A. Cohen Relation of brain natriuretic peptide levels to cognitive dysfunction in adults > 55 years of age with cardiovascular disease Am. J. Cardiol. 98 2006 538 540
125. T. Kerola, T. Nieminen, S. Hartikainen, R. Sulkava, O. Vuolteenaho, and R. Kettunen B-type natriuretic peptide as a predictor of declining cognitive function and dementia - a cohort study of an elderly general population with a 5-year follow-up Ann. Med. 42 2010 207 215
126. D.C. Lu, D.K. Binder, B. Chien, A. Maisel, and G.T. Manley Cerebral salt wasting and elevated brain natriuretic peptide levels after traumatic brain injury: 2 case reports Surg. Neurol. 69 2008 226 229
127. T. Nakamura, K. Sakamoto, T. Yamano, M. Kikkawa, K. Zen, T. Hikosaka, T. Kubota, A. Azuma, and T. Nishimura Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol. 39 2002 1657 1663
128. G.T. Jao, and J.R. Chiong Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options Clin. Cardiol. 33 2010 666 671
129. R. Gunathilake, C. Oldmeadow, M. McEvoy, B. Kelly, K. Inder, P. Schofield, and J. Attia Mild hyponatremia is associated with impaired cognition and falls in community-dwelling older persons J. Am. Geriatr. Soc. 61 2013 1838 1839
130. B. Renneboog, W. Musch, X. Vandemergel, M.U. Manto, and G. Decaux Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits Am. J. Med. 119 71 2006 e1 e8
131. S. Kalantarian, T.A. Stern, M. Mansour, and J.N. Ruskin Cognitive impairment associated with atrial fibrillation: a meta-analysis Ann. Intern. Med. 158 5 Pt 1 2013 338 346
132. J. Ball, M.J. Carrington, S. Stewart, and SAFETY investigators Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management? Heart 99 2013 542 547
133. R. Peters, and N. Beckett Atrial fibrillation is associated with an increased risk of cognitive and functional decline Evid. Based Med. 18 2013 e16
134. I. Marzona, M. O'Donnell, K. Teo, P. Gao, C. Anderson, J. Bosch, and S. Yusuf Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies CMAJ 184 2012 E329 E336
135. M.W. Rich Atrial fibrillation in long term care J. Am. Med. Dir. Assoc. 13 2012 688 691
136. H. Stefansdottir, S.O. Arnar, T. Aspelund, S. Sigurdsson, M.K. Jonsdottir, H. Hjaltason, L.J. Launer, and V. Gudnason Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts Stroke 44 2013 1020 1025
137. S. Knecht, C. Oelschläger, T. Duning, H. Lohmann, J. Albers, C. Stehling, W. Heindel, G. Breithardt, K. Berger, E.B. Ringelstein, P. Kirchhof, and H. Wersching Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy Eur. Heart J. 29 2008 2125 2132
138. F. Cacciatore, G. Testa, A. Langellotto, G. Galizia, D. Della-Morte, G. Gargiulo, A. Vevilacqua, M.T. Del Genio, V. Canonico, F. Rengo, and P. Abete Role of ventricular rate response on dementia in cognitively impaired elderly subjects with atrial fibrillation: a 10-year study Dement. Geriatr. Cogn. Disord. 34 2012 143 148
139. J.A. Dodson, T.T. Truong, V.R. Towle, G. Kerins, and S.I. Chaudhry Cognitive impairment in older adults with heart failure: prevalence, documentation, and impact on outcomes Am. J. Med. 126 2013 120 126
140. J.A. Dodson, and S.I. Chaudhry Geriatric conditions in heart failure Curr. Cardiovasc. Risk Rep. Oct. 6 2012 404 410
141. C.A. Luis, A.P. Keegan, and M. Mullan Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US Int. J. Geriatr. Psychiatry 24 2009 197 201
142. Z.S. Nasreddine, N.A. Phillips, V. Bédirian, S. Charbonneau, and V. Whitehead The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment J. Am. Geriatr. Soc. 53 2005 695 699
143. T. Smith, N. Gildeh, and C. Holmes The Montreal Cognitive Assessment: validity and utility in a memory clinic setting Can. J. Psychiatry 52 2007 329 332
144. P. Athilingam, K.B. King, S.W. Burgin, M. Ackerman, L.A. Cushman, and L. Chen Montreal Cognitive Assessment and Mini-Mental Status Examination compared as cognitive screening tools in heart failure Heart Lung 40 2011 521 529
145. S. Borson, J. Scanlan, M. Brush, P. Vitaliano, and A. Dokmak The Mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly Int. J. Geriatr. Psychiatry 15 2000 1021 1027
146. S.H. Tariq, N. Tumosa, J.T. Chibnall, M.H. Perry III, and J.E. Morley Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder - a pilot study Am. J. Geriatr. Psychiatry 14 2006 900 910
147. D.M. Cruz-Oliver, T.K. Malmstrom, C.M. Allen, N. Tumosa, and J.E. Morley The Veterans Affairs Saint Louis University mental status exam (SLUMS exam) and the mini-mental status exam as predictors of mortality and institutionalization J. Nutr. Health Aging 16 2012 636 641
148. D.M. Cruz-Oliver, and J.E. Morley Early detection of cognitive impairment: do screening tests help? J. Am. Med. Dir. Assoc. 11 2010 1 6
149. L. Feliciano, S.M. Horning, K.J. Klebe, S.L. Anderson, R.E. Cornwell, and H.P. Davis Utility of the SLUMS as a cognitive screening tool among a nonveteran sample of older adults Am. J. Geriatr. Psychiatry 21 2013 623 630
150. J.E. Morley Mild cognitive impairment - a treatable condition J. Am. Med. Dir. Assoc. 15 2014 1 5
151. S. Callegari, G. Majani, A. Giardini, A. Pierobon, C. Opasich, F. Cobelli, and L. Tavazzi Relationship between cognitive impairment and clinical status in chronic heart failure patients Monaldi Arch. Chest Dis. 58 2002 19 25
152. M.L. Alosco, M.B. Spitznagel, R. Cohen MB, L.H. Sweet, L.H. Colbert, R. Josephson, D. Waechter, J. Hughes, J. Rosneck, and J. Gunstad Cognitive impairment is independently associated with reduced instrumental activities of daily living in persons with heart failure J. Cardiovasc. Nurs. 27 2012 44 50
153. L.A. Hawkins, S. Kilian, A. Firek, T.M. Kashner, C.J. Firek, and H. Silvet Cognitive impairment and medication adherence in outpatients with heart failure Heart Lung 41 2012 572 582
154. K. Harkness, G.A. Heckman, N. Akhtar-Danesh, C. Demers, E. Gunn, and R.S. McKelvie Cognitive function and self-care management in older patients with heart failure Eur. J. Cardiovasc. Nurs. 13 2014 277 284
155. S.N. McLennan, S.A. Pearson, J. Cameron, and S. Stewart Prognostic importance of cognitive impairment in chronic heart failure patients: does specialist management make a difference? Eur. J. Heart Fail. 8 2006 494 501
156. G. Zuccalà, C. Pedone, M. Cesari, G. Onder, M. Pahor, E. Marzetti, M.R. Lo Monaco, A. Cocchi, P. Carbonin, and R. Bernabei The effects of cognitive impairment on mortality among hospitalized patients with heart failure Am. J. Med. 115 2003 97 103
157. A.E. Rogers, J.M. Addington-Hall, A.J. Abery, A.S. McCoy, C. Bulpitt, A.J. Coats, and J.S. Gibbs Knowledge and communication difficulties for patients with chronic heart failure: qualitative study BMJ 321 7261 2000 605 607
158. K.F. Hoth, A. Poppas, and K.E. Ellison Link between change in cognition and left ventricular function following cardiac resynchronization therapy J. Cardiopulm. Rehabil. Prev. 30 6 2010 401 408
159. D. Zimpfer, G. Wieselthaler, M. Czerny, R. Fakin, D. Haider, P. Zrunek, W. Roethy, H. Schima, E. Wolner, and M. Grimm Neurocognitive function in patients with ventricular assist devices: a comparison of pulsatile and continuous blood flow devices ASAIO J. 52 1 Jan-Feb 2006 24 27
160. N. Gruhn, F.S. Larsen, S. Boesgaard, G.M. Knudsen, S.A. Mortensen, G. Thomsen, and J. Aldershvile Cerebral blood flow in patients with chronic heart failure before and after transplantation Stroke 32 11 Nov 2001 2530 2533
161. G. Kozdaʇ, P. Işeri, G. Gökçe, G. Ertaş, F. Aygün, A. Kutlu, K. Hebert, and D. Ural Treatment with enhanced external counterpulsation improves cognitive functions in chronic heart failure patients Turk. Kardiyol. Dern. Ars. 41 5 Jul 2013 418 428
162. D. Tanne, D. Freimark, A. Poreh, O. Merzeliak, B. Bruck, Y. Schwammenthal, E. Schwammenthal, M. Motro, and Y. Adler Cognitive functions in severe congestive heart failure before and after an exercise training program Int. J. Cardiol. 103 2 Aug 18 2005 145 149
163. S. Carles Jr., D. Curnier, A. Pathak, J. Roncalli, M. Bousquet, J.L. Garcia, M. Galinier, and J.M. Senard Effects of short-term exercise and exercise training on cognitive function among patients with cardiac disease J. Cardiopulm. Rehabil. Prev. 27 6 Nov-Dec 2007 395 399
164. M.L. Alosco, M.B. Spitznagel, N. Raz, R. Cohen, L.H. Sweet, L.H. Colbert, R. Josephson, M. van Dulmen, J. Hughes, J. Rosneck, and J. Gunstad Dietary habits moderate the association between heart failure and cognitive impairment J. Nutr. Gerontol. Geriatr. 32 2 2013 106 121
165. G. Zuccalà, E. Marzetti, M. Cesari, M.R. Lo Monaco, L. Antonica, A. Cocchi, P. Carbonin, and R. Bernabei Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey Am. J. Med. 118 5 May 2005 496 502
166. A. Sinclair, J.E. Morley, and L. Rodriguez-Manas Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes J. Am. Med. Dir. Assoc. 13 2012 497 502
167. J.F. Flood, A.D. Mooradian, and J.E. Morley Characteristics of learning and memory in streptozocin-induced diabetic mice Diabetes 39 1990 1391 1398
168. V. Turchetti, M.A. Bellini, and L. Boschi Haemorheological and endothelial-dependent alterations in heart failure after ACE inhibitor, calcium antagonist and beta blocker Clin. Hemorheol. Microcirc. 27 2002 209 218
169. O.P. Almeida, and S. Tamai Clinical treatment reverses attentional deficits in congestive heart failure BMC Geriatr. 1 2001 2
170. G. Zuccala, G. Onder, and E. Marzetti Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure Eur. Heart J. 26 2005 226 233
171. J.F. Flood, and J.E. Morley Dose-response differences in the ability of Ramipril to improve retention in diabetic mice Eur. J. Pharmacol. 240 2-3 1993 311 314
172. J.E. Morley Mild cognitive impairment - a treatable condition J. Am. Med. Dir. Assoc. 15 2014 1 5
173. J.E. Morley Alzheimer's disease: future treatments J. Am. Med. Dir. Assoc. 12 2011 1 7
174. A. Sanford, and J.E. Morley Are the new guidelines for cholesterol and hypertension age friendly? J. Am. Med. Dir. Assoc. 15 2014 373 375
175. J. Mathillas, B. Olofsson, H. Lövheim, and Y. Gustafson Thirty-day prevalence of delirium among very old people: a population-based study of very old people living at home and in institutions Arch. Gerontol. Geriatr. 57 3 Nov-Dec 2013 298 304
176. S. Uthamalingam, G.S. Gurm, M. Daley, J. Flynn, and R. Capodilupo Usefulness of acute delirium as a predictor of adverse outcomes in patients > 65 years of age with acute decompensated heart failure Am. J. Cardiol. 108 3 Aug 1 2011 402 408
177. D. Parente, C. Luís, D. Veiga, H. Silva, and F. Abelha Congestive heart failure as a determinant of postoperative delirium Rev. Port. Cardiol. 32 9 Sep 2013 665 671
178. A. Cherubini, D.T. Lowenthal, E. Paran, P. Mecocci, L.S. Williams, and U. Senin Hypertension and cognitive function in the elderly Dis. Mon. 56 3 Mar 2010 106 147
179. R.Y. Lin, L.C. Heacock, G.A. Bhargave, and J.F. Fogel Clinical associations of delirium in hospitalized adult patients and the role of on admission presentation Int. J. Geriatr. Psychiatry 25 10 Oct 2010 1022 1029
180. M. Chan, F. Nicklason, and J.H. Vial Adverse drug events as a cause of hospital admission in the elderly Int. Med. J. 31 4 May-Jun 2001 199 205
181. S. Keller, and W.H. Frishman Neuropsychiatric effects of cardiovascular drug therapy Cardiol. Rev. 11 2003 73 93
182. R.W. Pretorius, G. Gataric, S.K. Swedlund, and J.R. Miller Reducing the risk of adverse drug events in older adults Am. Fam. Physician 87 5 Mar 1 2013 331 336
183. A. Banerjee, E. Wesley Ely, P.P. Pandharipande, J.L. Vincent, E. Abraham, F.A. Moore, P.M. Kachanek, and M.P. Fink Agitation and delirium Textbook of critical care 6th edition 2011 Elsevier Saunders
184. K. Shadvar, F. Baastani, A. Mahmoodpoor, and E. Bilehjani Evaluation of the prevalence and risk factors of delirium in cardiac surgery ICU J. Cardiovasc. Thorac Res. 5 4 2013 157 161